Headlines: Cigna Sells Medicare Plans, Sickle Cell Therapy Access Grows
Cigna is shedding its Medicare plans, selling them to HCSC. Meanwhile, the White House is eyeing sickle cell therapies and their high price tags.
Cigna is shedding its Medicare plans, selling them to HCSC. Meanwhile, the White House is eyeing sickle cell therapies and their high price tags.